missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Nährmedien, Supplemente und Reagenzien für die Zellkultur
  4. Zellkulturmedien
  5. Cell Target Typ Zellkulturmedien
  6. Medien zur Anzucht von Hybridom- und Myelomzellen
  7. 17191026

STEMCELL Technologies ClonaCell™-HY Medium C

Artikelnummer. 17191026
Encompass
Ansicht ändern
Click to view available options
Menge:
100 ml
Packungsgröße:
100 Milliliter
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Artikelnummer. Menge Packungsgröße
17191026 100 ml 100 Milliliter
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen
Artikelnummer. 17191026 Lieferant STEMCELL Technologies Lieferanten-Nr. 03803
 Eingeschränkter Artikel
Verfügbar ab: 03-11-2026
Zum Warenkorb hinzufügen
Zum Warenkorb hinzufügen

missing translation for 'validMainframeMsg'

Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen

Beschreibung

Hybridoma fusion recovery medium (serum-containing)

  • ClonaCell™-HY Medium C is a serum-containing liquid medium used to promote hybridoma viability and recovery after the fusion process (PEG-based or electrofusion) and prior to hypoxanthine, aminopterin, thymidine (HAT) selection
  • This medium has been verified for use in mouse and rat hybridoma development and reportedly is compatible for production of hybridomas using lymphocytes from a variety of host animals including human, mouse, rat, and hamster

Specifications

Zelltyp Hybridome
Zur Verwendung mit (Anwendung) Cell Culture; Hybridoma Generation
Menge 100 ml
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.